April 2012 | OncologyLive

Five Questions for Leonard M. Neckers, PhD

April 24, 2012

Leonard M. Neckers, PhD, has been studying the role of the molecular chaperone Hsp90 in signal transduction and the translational development of Hsp90-targeted anticancer agents for two decades.